Pulmonx Corporation (LUNG)
NASDAQ: LUNG · IEX Real-Time Price · USD
7.92
-0.05 (-0.63%)
At close: Jul 19, 2024, 4:00 PM
7.87
-0.05 (-0.63%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Pulmonx Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Pulmonx stock have an average target of 15.25, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 92.55% from the current stock price of 7.92.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 4, 2024.
Analyst Ratings
The average analyst rating for Pulmonx stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +51.52% | Jun 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +89.39% | May 2, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $17 | Buy | Reiterates | $17 | +114.65% | Apr 3, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $16 → $17 | Strong Buy | Maintains | $16 → $17 | +114.65% | Feb 23, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $16 → $14 | Buy → Hold | Downgrades | $16 → $14 | +76.77% | Feb 23, 2024 |
Financial Forecast
Revenue This Year
84.25M
from 68.68M
Increased by 22.68%
Revenue Next Year
100.13M
from 84.25M
Increased by 18.85%
EPS This Year
-1.72
from -1.60
EPS Next Year
-1.60
from -1.72
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 87.7M | 106.7M | 129.9M | 150.9M |
| Avg | 84.2M | 100.1M | 120.5M | 146.6M |
| Low | 79.4M | 93.2M | 110.8M | 140.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 27.7% | 26.6% | 29.7% | 25.3% |
| Avg | 22.7% | 18.9% | 20.3% | 21.7% |
| Low | 15.6% | 10.6% | 10.7% | 16.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.70 | -1.45 | -0.96 | -0.79 |
| Avg | -1.72 | -1.60 | -1.26 | -0.77 |
| Low | -1.73 | -1.67 | -1.58 | -0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.